Development backgroundHow to quickly analyze and track the R&D progress of competitors is a problem that all new drug R&D companies need to solve. After a new patent on a popular target is published, there will often be a large number of followers competing in this field. How to obtain the SAR information in patent documents in the first time…
2023/05/24
R&D BackgroundHow to quickly analyze and track the R&D progress of competitors is a problem that all new drug R&D companies need to solve. After a new patent on a popular target is published, there will often be a large number of followers competing in this field. How to obtain the SAR information in patent documents in the first time…
2023/03/22
August 30th, 2021- Simcere Pharmaceutical Group Co., Ltd. (2096.HK, hereinafter referred to as "Simcere") and AlphaMa Biotechnology Co., Ltd. (hereinafter referred to as "AlphaMa") jointly announced that they have successfully signed an exclusive license agreement for the new anti-tumor drug ALM005 . According to the agreement, Simcere Pharmaceuticals will obtain the rights to develop all indications of ALM005 and commercialize…
2021/09/01
AlphaMa Biotech (“AlphaMa”) is pleased to announce that the company has entered into a research collaboration with Eli Lilly and Company (“Lilly”) to utilize AlphaMa’s proprietary intelligent DNA-encoded libraries (“iDEL”) for drug discovery and development in selected therapeutic areas. AlphaMa has established a unique platform that integrates DNA-encoded library (DEL) and Artificial Intelligence (AI) for small molecule drug discovery. With…
2021/07/24
After three months of fierce competition, the Bristol-Myers Squibb-Molecular Translation Competition organized by Kaggle, a well-known data science competition platform, ended at 8 a.m. Beijing time on June 4th. The competition attracted nearly a thousand data scientists from all over the world. The final winner, called SIMM DDDC, is a joint team composed of Dr. Xiaohong Liu from AlphaMa Biotechnology…
2021/06/10
Alphama PatMap patent analysis platform is online！
PatMap patent analysis software has been launched
Simcere Pharmaceuticals and AlphaMa Biotech signed an exclusive license agreement for the new anti-tumor drug ALM005
AlphaMa and Lilly Collaborate on Drug Discovery Based on Intelligent DNA-Encoded Libraries
AlphaMa & SIMM Joint Team Won the Champion of the International Molecular Translation Challenge
